Replimune Group Stock (NASDAQ: REPL) stock price, news, charts, stock research, profile.
You can purchase shares of Replimune Group (NASDAQ:REPL) through any online brokerage.
Other companies in Replimune Group’s space includes: ARS Pharmaceuticals (NASDAQ:SPRY), 89bio (NASDAQ:ETNB), Gyre Therapeutics (NASDAQ:GYRE), Upstream Bio (NASDAQ:UPB) and Cogent Biosciences (NASDAQ:COGT).
Replimune Group has a consensus price target of $31.38.
The stock price for Replimune Group (NASDAQ: REPL) is $12.49 last updated December 20, 2024 at 4:00 PM EST.
There are no upcoming dividends for Replimune Group.
Replimune Group’s Q3 earnings are confirmed for Thursday, February 6, 2025.
There is no upcoming split for Replimune Group.
Replimune Group is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.